Cooper A D, Craig W Y, Taniguchi T, Everson G T
Department of Medicine, Stanford University School of Medicine, California 94305.
Hepatology. 1994 Dec;20(6):1522-31. doi: 10.1002/hep.1840200623.
Bile salt uptake, synthesis and secretion by the human hepatoma-derived cell line HepG2 were studied. The cells transported and secreted bile salts largely by means of passive mechanisms. The cells synthesized and secreted the normal human primary bile salts. The ratio of cholate to chenodeoxycholate was 1.5:1. The degree of conjugation, about 35%, was lower than normal, and the glycine-to-taurine ratio was abnormal (4.5:1). This was not due to amino acid deficiency in the medium. Contrary to the report of others, little 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestan-26-oic acid was secreted. This was confirmed by gas chromatography-mass spectrometry. The total rate of synthesis was about 33% that of normal liver. The specific activity of bile salts synthesized from [3H]mevalonate was about 20 times higher than that of the cellular cholesterol derived from the same precursor. The regulation of bile salt synthesis by two compounds that could alter the precursor pool of cholesterol was studied. After a 24-hr incubation in serum-free medium, the compound 25(OH)cholesterol inhibited the rate of bile salt synthesis compared with control values, possibly by depleting the intracellular free cholesterol pool. Surprisingly, however, progesterone, which inhibits cholesterol esterification and should have expanded this pool, also inhibited bile salt synthesis under those conditions. The effect of these compounds on the level of mRNA for cholesterol 7 alpha-hydroxylase was also determined by Northern-blot analysis. The cholesterol 7 alpha-hydroxylase mRNA was 3.7 kb, similar to that in the rat. The incubation of cells in 25(OH)cholesterol or progesterone, as above, resulted in a decreased level of mRNA. The reduction was proportional to the reduction in bile salt synthesis, suggesting that these compounds act at a pretranslational level. Taken together, these results suggest that our particular subclone of HepG2 cells will be useful for studies of the regulation of bile salt synthesis, but not of transport, by human liver-derived tissue.
对源自人肝癌的细胞系HepG2的胆盐摄取、合成及分泌进行了研究。这些细胞主要通过被动机制转运和分泌胆盐。细胞合成并分泌正常人的初级胆盐。胆酸与鹅脱氧胆酸的比例为1.5:1。结合程度约为35%,低于正常水平,且甘氨酸与牛磺酸的比例异常(4.5:1)。这并非由于培养基中氨基酸缺乏所致。与其他人的报告相反,几乎没有分泌3α,7α,12α - 三羟基 - 5β - 胆甾烷 - 26 - 酸。这通过气相色谱 - 质谱法得到了证实。合成的总速率约为正常肝脏的33%。由[3H]甲羟戊酸合成的胆盐的比活性比源自相同前体的细胞胆固醇的比活性高约20倍。研究了两种能够改变胆固醇前体库的化合物对胆盐合成的调节作用。在无血清培养基中孵育24小时后,与对照值相比,化合物25(OH)胆固醇抑制了胆盐合成速率,可能是通过消耗细胞内游离胆固醇库。然而,令人惊讶的是,抑制胆固醇酯化且本应扩大该库的孕酮,在这些条件下也抑制了胆盐合成。还通过Northern印迹分析确定了这些化合物对胆固醇7α - 羟化酶mRNA水平的影响。胆固醇7α - 羟化酶mRNA为3.7 kb,与大鼠中的相似。如上述在25(OH)胆固醇或孕酮中孵育细胞导致mRNA水平降低。这种降低与胆盐合成的降低成比例,表明这些化合物在翻译前水平起作用。综上所述,这些结果表明我们特定的HepG2细胞亚克隆将有助于研究人肝脏来源组织对胆盐合成而非转运的调节。